Mycetoma

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 565-568

  Fahal, Ahmed Hassan ^a  

^a UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869878969     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00083-5     Document Type: Chapter

References (19)

1. Fahal AH Mycetoma thorn on the flesh. Trans R Soc Trop Med Hyg 2004, 98(1):3.
2. Ahmed AA, van de Sande WW, Fahal A, et al. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 2007, 20(2):146.
3. Quintana ET, Wierzbicka K, Mackiewicz P, et al. Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma. Antonie Van Leeuwenhoek 2008, 93(3):305.
4. Fahal AH, Hassan MA Mycetoma. Br J Surg 1992, 79(11):1138.
5. Ahmed AO, van Leeuwen W, Fahal A, et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004, 4(9):566.
6. Arbab MAR, Elhag IA, Abdul Gadir AF, et al. Intraspinal mycetoma: report of two cases. Am J Trop Med Hyg 1997, 56:27.
7. Fahal AH, Sheikh HE, EL Hassan AM Pathological fracture in mycetoma. Trans. R Trop Med Hyg 1996, 90:675.
8. Fahal AH, EL Toum EA, EL Hassan AM, et al. Host tissue reaction to Madurella mycetomatis: new classification. J Med Vet Mycol 1995, 33:15.
9. Fahal AH, Sheikh HE, EL Lider MA, et al. Ultrasonic imaging in mycetoma. Br J Surg 1997, 78:765.
10. el Hag IA, Fahal AH, Khalil EAG Fine needle aspiration cytology of mycetoma. Acta Cytol 1996, 40(3):461.
11. Ahmed AO, Mukhtar MM, Kools-Sijmons M, et al. Development of a species-specific PCR RFLP procedure for the identification of Madurella mycetomatis. J Clin Microbiol 1999, 37(10):3175.
12. Ahmed AOA, van de Sande W, Van Belkum A, et al. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol 2003, 41(10):4537.
13. el Hassan AM, Fahal AH, Ahmed AO, et al. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Med Hyg 2001, 95(1):89.
14. Fahal AH The management of mycetoma. Post-Graduate 2000, 16(4):229.
15. Welsh O, Sauceda E, Gonzalez J, et al. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol 1987, 17(3):443.
16. Damle DK, Mahajan PM, Pradhan SN, et al. Modified Welsh regimen: a promising therapy for actinomycetoma. J Drugs Dermatol 2008, 7(9):853.
17. Ahmed AO, van de Sande WW, van Vianen W, et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-te trazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 2004, 48(7):2742.
18. van de Sande WW, de Kat J, Coppens J, et al. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect 2007, 9:1114.
19. Mahgoub ES, Gumaa SA Ketoconazole in the treatment of eumycetoma due to Madurella mycetomi. Trans R Soc Trop Med Hyg 1984, 78:376.